Inventor
KALLA RAO V
US31 patents
⚠️ This page may combine multiple inventors who share the name “KALLA RAO V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
28 patentsUS12180217B2Dec 31, 2024
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC3 citations84
US11939347B2Mar 26, 2024
1′-cyano nucleoside analogs and uses thereof
GILEAD SCIENCES INC7 citations84
US11926645B2Mar 12, 2024
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC8 citations84
US11851438B2Dec 26, 2023
1′-cyano nucleoside analogs and methods for treatment of viral infections
GILEAD SCIENCES INC9 citations84
US11845755B2Dec 19, 2023
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC7 citations84
US11814406B2Nov 14, 2023
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC11 citations84
US11780844B2Oct 10, 2023
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC7 citations84
US9676760B2Jun 13, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC7 citations84
US9598435B2Mar 21, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC9 citations84
US9193694B2Nov 24, 2015
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC11 citations84
US11203591B2Dec 21, 2021
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC6 citations82
US12297226B2May 13, 2025
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC3 citations73
US9403782B2Aug 2, 2016
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC4 citations73
US11925631B2Mar 12, 2024
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC2 citations72
US11071730B2Jul 27, 2021
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC4 citations72
US11897878B2Feb 13, 2024
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC2 citations71
US11453681B2Sep 27, 2022
Substituted eneoxindoles and uses thereof
GILEAD SCIENCES INC2 citations70
US12448383B2Oct 21, 2025
Compounds and methods for treatment of viral infections
GILEAD SCIENCES INC0 citations61
US12404289B2Sep 2, 2025
1′-cyano nucleoside analogs and uses thereof
GILEAD SCIENCES INC0 citations61
US12258346B2Mar 25, 2025
Substituted 6-azabenzimidazole compounds
GILEAD SCIENCES INC0 citations61
US11229638B2Jan 25, 2022
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC0 citations61
US11040033B2Jun 22, 2021
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC1 citations61
US12037342B2Jul 16, 2024
Substituted eneoxindoles and uses thereof
GILEAD SCIENCES INC0 citations60
US12116380B2Oct 15, 2024
Phospholipid compounds and methods of making and using the same
GILEAD SCIENCES INC0 citations58
US9695192B2Jul 4, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC0 citations52
US9682998B2Jun 20, 2017
Fused heterocyclic compounds as ion channel modulators
GILEAD SCIENCES INC0 citations52
US11186579B2Nov 30, 2021
Therapeutic heterocyclic compounds
GILEAD SCIENCES INC0 citations50
US10100058B2Oct 16, 2018
Fused heterocyclic compounds as CaM kinase inhibitors
GILEAD SCIENCES INC0 citations41
CORKEY BRITTON KENNETH
3 patentsUS8586732B2Nov 19, 2013
Fused heterocyclic compounds as ion channel modulators
CORKEY BRITTON KENNETH29 citations91
US9115096B2Aug 25, 2015
Fused heterocyclic compounds as ion channel modulators
CORKEY BRITTON KENNETH5 citations83
US8962610B2Feb 24, 2015
Fused heterocyclic compounds as ion channel modulators
CORKEY BRITTON KENNETH6 citations83